Estimaciones de analistas de Wall Street para Mondelez International, Inc. (MDLZ): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-10-27 | $0.72 | ||
| 2026-07-28 | $0.73 | $0.68 | +7.4% |
| 2026-04-28 | $0.67 | $0.61 | +10.2% |
| 2026-02-03 | $0.72 | $0.70 | +3.4% |
| 2025-10-28 | $0.73 | $0.72 | +0.8% |
| 2025-07-29 | $0.73 | $0.68 | +7.8% |
| 2025-04-29 | $0.74 | $0.65 | +13.1% |
| 2025-02-04 | $0.65 | $0.66 | -1.2% |
Ratios de valoración
| Ratio P/E | 28.73 |
| Precio / Valor contable | 2.72 |
| EV / EBITDA | 19.32 |
| Rentabilidad por dividendo | 3.54% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $25.92B | $25.90B | $25.94B | $25.87B | $26.58B | $28.72B | $31.50B | $36.02B | $36.44B | $38.54B |
| Coste de Ventas | $15.82B | $15.86B | $15.59B | $15.53B | $16.14B | $17.47B | $20.18B | $22.25B | $22.18B | $27.60B |
| Beneficio Bruto | $10.10B | $10.03B | $10.35B | $10.34B | $10.45B | $11.25B | $11.31B | $13.76B | $14.26B | $10.94B |
| I+D | 0 | 0 | 0 | 0 | 0 | $347.0M | 0 | 0 | 0 | 0 |
| Generales y Administrativos | $6.55B | $5.94B | $6.47B | $6.14B | $6.10B | $6.26B | $7.38B | $8.00B | $7.44B | $7.17B |
| Gastos Operativos | $7.55B | $6.57B | $7.04B | $6.49B | $6.59B | $6.60B | $7.78B | $8.26B | $7.91B | $7.32B |
| Beneficio Operativo | $2.55B | $3.46B | $3.31B | $3.84B | $3.85B | $4.65B | $3.53B | $5.50B | $6.34B | $3.62B |
| EBITDA | $2.79B | $4.34B | $4.12B | $4.98B | $4.92B | $5.85B | $4.76B | $7.64B | $8.07B | $4.65B |
| Gastos por Intereses | $515.0M | $396.0M | $462.0M | $484.0M | $423.0M | $365.0M | $428.0M | $550.0M | $508.0M | $599.0M |
| Beneficio Antes de Impuestos | $1.76B | $3.51B | $4.10B | $3.95B | $4.79B | $5.50B | $3.59B | $6.50B | $6.09B | $3.25B |
| Impuestos | $114.0M | $666.0M | $773.0M | $2.0M | $1.22B | $1.19B | $865.0M | $1.54B | $1.47B | $782.0M |
| Beneficio Neto | $1.64B | $2.83B | $3.32B | $3.93B | $3.56B | $4.30B | $2.72B | $4.96B | $4.61B | $2.45B |
| BPA | $1.07 | $1.93 | $2.30 | $2.68 | $2.48 | $3.06 | $1.97 | $3.64 | $3.44 | $1.89 |
| BPA Diluido | $1.05 | $1.91 | $2.28 | $2.65 | $2.47 | $3.04 | $1.96 | $3.62 | $3.42 | $1.89 |
| Acciones en Circulación (Diluidas) | $1.57B | $1.53B | $1.49B | $1.46B | $1.44B | $1.41B | $1.39B | $1.37B | $1.35B | $1.30B |
Precio
| Precio | $62.36 |
| Capitalización | $79.6B |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: CCEP · CL · DEO · HSY · K · KDP · KR
Explorar sector: Consumer Defensive · Food Confectioners
Más secciones de MDLZ: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones